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Abstract Addition of the phospholipids 1-O-hexadecyl-2-arachi- 
donoyl-sn-glycero-3-phosphocholine (PLE) and 1-O-hexa- 
decyl-2-desoxy-2-amino-ar achidonoyl-sn-glycero-3-phosphocholine 
(PLA) to [~2SIILDL and subsequent Cu2+-induced oxidation result 
in significant differences in protein modification and uptake by 
P388D~ macrophage-like cells. PLE-treated LDL is ingested at 
a 1.27-fold rate compared to PLE-treated LDL and displays 
enhanced electrophilic mobility. Similar results (1.43-fold en- 
hanced uptake of LDL preloaded with PLE) are obtained when 
the uptake of phospholipid-enriched oxLDL particles are exam- 
ined. The preference for ingestion as well as protein modification 
of both preparations is, however, reversed under experimental 
conditions allowing diffusion and inactivation of a fraction of the 
peroxidation products. These findings suggest hat LDL-associ- 
ated PAF-acetylhydrolase can exert a dual role and, to be protec- 
tive to LDL, require an appropriate microenvironment, capable 
of binding certain species of oxidatively fragmented lipids. 
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I. Introduction 
Oxidation of LDL, an event generally thought o be critical 
in the development of atherosclerosis [1 6], is accompanied by 
the generation of lysophospholipids [7]. One source of phos- 
pholipase activity, a PAF-acetylhydrolase [8], has been identi- 
fied, an enzyme which is associated with low and high density 
lipoproteins (LDL and HDL) in human plasma [9,10]. It is 
Ca2+-independent a d exhibits an apparent molecular weight 
of 43.000 kDa [11,12]. The enzyme is secreted by human mac- 
rophages [13] and exerts a marked substrate specifity for PAF 
and phospholipids carrying short and polar sn-2 residues. It has 
been demonstrated recently that phospholipids carrying unsat- 
urated fatty acids like arachidonic acid at the sn-2 position are 
fragmented by peroxidative processes to afford biologically 
active PAF-like compounds. These products are also substrates 
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of PAF-acetylhydrolase [14- 16], suggesting the possibility that 
this enzyme affects the concentration and half-life of oxida- 
tively degraded phospholipids in vivo. 
Lipid peroxide decomposition products cause derivatization 
of the LDL apolipoprotein B100 (apo B100) [17]; scavenger- 
mediated uptake of LDL by macrophages apparently involves 
the modification of the e-amino groups of apo B100 lysines 
[18-20]. Therefore, factors enhancing LDL modification may 
be critical in the development and progression of atheroscle- 
rotic lesions. Reaction of LDL with lipid peroxidation products 
and aldehydes results in increased uptake of such modified 
particles by macrophages, leading to an accumulation of lipids 
and subsequently to a conversion of macrophages to foam cells 
[21]. Since PAF-acetylhydrolase catalyzes the hydrolysis of 
fragments derived from polyunsaturated phospholipids [14], 
the enzyme may affect the composition of oxidation products 
and thereby their potential to act as LDL-modifying agents. If 
this hypothesis correct, PAF-AH should modulate the degree 
and type of LDL modification which determines the degree of 
interaction with the scavenger receptor. Thus, the action of 
PAF-acetylhydrolase on oxidatively fragmented phospholipids 
could be critical in atherogenesis. 
In this study we provide evidence that modification and cel- 
lular uptake of oxidizing LDL is modulated by the susceptibil- 
ity of phospholipids toenzymatic hydrolysis, and that the PA F- 
acetylhydrolase, as well as other phospholipases, could play a 
dual role in LDL modification, depending on their microenvi- 
ronments. 
2. Materials and methods 
2.1. Materials" 
Chemicals were purchased from Aldrich Chemical Co. (Steinheim, 
Germany), Fluka (Neu-Ulm, Germany) and E. Merck (Darmstadt, 
Germany). Biochemicals were obtained from Boehringer Mannheim 
GmbH (Mannheim, Germany), Sigma (Munich, Germany) or Serva 
(Heidelberg, Germany). Material for cell culture was obtained from 
Nunc (Wiesbaden, Germany). [3H]Arachidonic acid, [3H]PAF and 
[t4C]PAF were products of DuPont de Nemours (NEN. Bad Homburg, 
Germany). 
[IzSI]LDL (7.70 TBq/mmol), prepared according to the method of 
Sinn et al. [22], was purchased from Immuno Diagnostik GmbH 
(Bensheim, Germany) and diluted with unlabeled LDL to attain a 
specific activity of 100 kBq/mg protein. 
Protein concentration was determined using the BCA protein assay 
(Pierce Chemical Co., Rockford, IL, USA) and BSA as the standard. 
1-O-Hexadecyl-2-arachidonoyl-sn-glycero-3-phosphocholine was pur- 
chased from Biomol (Hamburg, Germany). Chloroform and methanol 
were distilled from P205 and from Mg prior to use. Silica gel (grade 60, 
70~230 mesh) for column chromatography was from Machery-Nagel 
(Diiren, Germany); TLC plates for analytical nd preparative use (0.25 
and 1 mm, F 254) were from E. Merck (Darmstadt, Germany) and were 
pre-eluted with methanol. Phospholipids were spotted with Phospray 
(Supelco, Bad Homburg, Germany) on TLC. Proton nuclear magnetic 
resonance spectra were obtained on a Bruker WM 300 spectrometer 
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(Bruker Physik AG, Karlsruhe, Germany) and proton chemical shifts 
are relative to tetramethylsilane (TMS), the internal reference. The 
spectra were run in CDCIs and multiplicities are reported as singlet (s), 
doublet (d), triplet (t) or multiplet (m). FAB mass spectra were recorded 
on a MAT 311 A (Varian, Bremen, Germany) using a FAB gun from 
Ion Tech (Teddington, UK) and glycerol as matrix (Xe, 6 kV, ion 
current = 1 mA). LSC counting was performed on an Isocap 300 
(Searle, Chicago, USA). t25I radioactivity was quantified with a LKB- 
Wallac RiaGamma 1274 (Turku, Finland). 
2.2. LDL-preparation and (co)oxidation, preparation of phospholipid- 
enriched LDL 
LDL was isolated from pooled human plasma containing EDTA 
(1 mg/ml) by sequential f otation in an ultracentrifuge at preselected 
densities (between 1.019 and 1.063 g/ml) as described [23] and dialyzed 
extensively against Tris-buffer (20 mM, pH 7.8, 150 mM NaCI, 0.2 mM 
EDTA); LDL was kept sterile under nitrogen in Tris-buffer at 4°C and 
used within 2 weeks. For oxidation, LDL was dialyzed against the same 
buffer (except EDTA) prior to use. Oxidation of 125I-labeled LDL 
(100 kBq/mg protein, 1 mg of protein/ml) was carried out in Tris-buffer 
by addition of CUSO4(20/aM) and incubation for up to 24 h at 37°C. 
Reactions were stopped by addition of EDTA (0.2 raM) and BHT 
(20/aM). For co-oxidation with phospholipids, phospholipids were 
added in Tris-buffer (20 raM; pH 7.8) to attain a final concentration 
of 300/aM. 
[125I]LDL enriched with PLA or PLE was obtained according to a 
published protocol [18]. Briefly, PLE and PLA phospholipids were 
dissolved in ethanol and dried under N2 in a silanized glass tube. Then 
phosphate buffered saline and 2.5 mg of protein of a density > 1.21 g/ml 
plasma fraction (as a source of plasma transfer proteins) were added, 
and the mixture (PLE 300/aM or PLA 300/aM) was vortexed vigor- 
ously for 1 min. To an aliquot of these mixtures [~25I]LDL (1.7 MBq/mg, 
1 mg/ml, EDTA 0.2 mM, BHT 20/aM) was then added and the samples 
were incubated for 1 h at 37°C. LDL was re-isolated by density gradient 
ultracentrifugation as described, dialyzed, and oxidation was per- 
formed as outlined above. To modify native LDL with oxidized 
phospholipids, PLE and PLA were oxidized (CuSO4 20/aM, 24 h, 37 ° C) 
followed by a 1 h incubation with native [~25I]LDL at 37°C (PLE 
300/aM or PLA 300/aM) and subsequent dialysis against Tris-buffer 
(20 raM; pH 7.8, EDTA 0.2 mM, BHT 20/aM) to obtain phospholipid- 
modified [~25I]LDL (100 kBq/mg). In some experiments immobilized 
PLA2 attached to beaded agarose (bee venom 4200 units/g; Sigma, 
Deisenhofen, Germany) was added to the oxidized lipids (10 units/300 
/21, phospholipids 300/aM) and the samples were incubated at 37°C 
(0.5 h). Prior to addition to the LDLs, the PLA2 was separated by 
centrifugation (5 min, 1500 × g). 
2.3. Synthesis of phospholipids 
PLA was prepared by a route via 1-O-hexadecyl-2-(S)-amino- 
propanol as published by this laboratory previously [24]. The reaction 
of 1-O-hexadecyl-2-desoxy-2-amino-sn-glycero-3-phosphocholine (50 
mg, 0.104 mmol) with arachidonic acid (300.4 mg, 1 retool) was per- 
formed in chloroform in the presence of DCC (35.4 mg, 0.3 mmol) and 
DMAP (183.3 mg, 1.5 mmol) at room temperature. Stirring for 18 h 
under an argon atmosphere yielded crude 1-O-hexadecyl-2-desoxy-2- 
amino-arachidonoyl-sn-glycero-3-phosphocholine purified by column 
chromatography eluting first with a mixture of chloroform/methanol 
(5 : 1, v/v), then with chloroform/methanol/water (65 : 45 : 8, v/v). Sub- 
sequent preparative TLC (elution with chloroform/methanol/water 
65:45:8, v/v, under argon) and extraction with chloroform/methanol 
(5:1, v/v) afforded 30.7 mg (0.04 mmol, 40%) of pure compound. 
1-O- Hexadecyl-2-desoxy-2-amino-5,6,8,9,11,12,14,15-[3H]arachido - 
noyl-sn-glycero-3-phosphocholine (4.2 mg, 0.0055 mmol, 45 MBq/mM) 
was synthesized and purified in an analogous way using [3H]ara- 
chidonic acid (21 mg, 0.07 mmol, 45 MBq/mmol) in the presence of 
DCC (2.4 mg, 0.02 mmol) and DMAP (12.3 mg, 0.1 mmol). The con- 
centration of phospholipid-containing samples was estimated by phos- 
phate determination according to Ames and Dubin [25]. 
MS (FAB, glycerol, pos. mode): m/z = 767 [M + H] +. ~H NMR 
(CDC13) ~ ppm: 0.85 (6H, m, -CH3), 1.25 (34H, m, -(CH2)14-CH3; 
-(CH2)s-CH3), 1.5 (2H, m, -O-CH2-(CH)~4-CH3), 1.65 (2H, m, -NH- 
CO-CH2-CH:-), 2.0 2.1 (4H, m, -CH2-CH -- CH-), 2.3 (2H, t, -CO- 
CH2-), 2.8 (6H, m, -CH = CH-CHe-CH =CH-), 3.32 (9H, s, - 
N+(CH3)s), 3.55 (2H, m, -CH2-N+(CH3)3), .7 (1H, m, -CH-NH-), 3.75 
(2H, m, -CH-CH2-O-CH2), 3.9 (2H, m, -CH-CH2-O-P-), 4.3 (2H, m, 
-P-O-CH2-CH2), 5.35 (8H, m, -CH= CH-). Tritiated phospholipids 
were characterized by FAB-MS. 
2.4. Cell Culture, uptake of lipoproteins 
The P388D l macrophage c ll line (clone 3124, provided by American 
Type Culture Collection, MD, USA) was cultered at 37°C in RPMI 
1640 supplemented with glutamine (2 raM), 10% heat inactivated fetal 
calf serum (FCS), penicillin (50 units/ml) and streptomycin (50/ag/ml) 
in a humidified atmosphere (5% CO2:95% air). 
Uptake studies were carried out using cultured macrophages (3 x 10 6) 
in 50 ram-dishes (Greiner, Frickenhausen, Germany). 2h after seeding, 
the macrophages were treated with LPS (Escherichia coli, serotype 
026:B6, 100 ng/ml) for 1 h at 37°C, washed three times with 
2 ml of HBSS and incubated with another 2ml of HBSS for 20 rain at 
37°C. After the preincubation, HBSS was removed and 1.5 ml HBSS 
containing 0.1% of BSA and t25I-labeled lipoproteins (80/ag protein/ 
dish) were added for 30 min at 37°C. The cells were washed three times 
with 1.5 ml of ice-cold HBSS and then solubilized with 1.0 ml sodium 
hydroxide (0.3 M) and Triton X-100 (0.1%) for 1 h at 37°C. Aliquots 
were taken for determination of radioactivity (500/al) and protein 
content (5/11). 
2.5. Electrophoresis 
The electrophoretic mobility (30 mA, 50 V, 1.5 h) of the lipoproteins 
was determined in an agarose gel (1.0%) in Tris-CH3COOH (pH 8.3, 
8 mM) supplemented with EDTA (0.2 mM). Protein staining was car- 
ried out with Coomassie blue R250. The electrophoretic mobility was 
determined relative to bromophenol b ue. 
2.6. Determination freactive lysines 
The number of lysine residues was measured by titration with TNBS 
as described [26] using valine as standard. LDL (5/ag) was mixed with 
100/al NaHCO3 (4%, w/v) and 5/al of TNBS (0.1%, w/v). After incuba- 
tion for 1 h at 37°C, 10/al of HC1 (1 mol) and 10/al of SDS (10%) were 
added. 
2.7. PAF-acetylhydrolase assay 
An aliquot of the respective lipoprotein (30 pg) was transfered to a 
substrate solution ([3H]PAF, 200/aM) and incubated for 1 h at 37°C. 
The reaction was stopped by the addition of glacial acetic acid (20/al), 
and N-methyl-[laC]PAF (5 kBq/sample) was added as internal stan- 
dard. The lipids were extracted according to the method of Bligh and 
Dyer [27], and the lyso-PAF concentration was determined by TLC 
separation and scraping of spots visualized with Phospray by liquid 
scintillation counting. 
3. Results 
The aim of this study was to analyze the effect of LDL- 
associated phosphol ipase activity on the oxidative modification 
of LDL by supplementat ion with two ether phospholipids, PLE 
and PLA. Phospholipids carrying an arachidonic acid ester at 
the sn-2 position are natural  components of the l ipoprotein [28] 
and are degraded in the course of lipid peroxidation [29]. The 
two compounds used in this study differ only at the sn-2 posi- 
tion: whereas PLE carries an ester oxygen, the other com- 
pound (PLA) is substituted with an amide nitrogen. This differ- 
ence creates significant differences in hydrolytic stability as 
shown for the analogue 2-amino-2-desoxy-acetyl-PAF [30]. 
Also, the replacement of the ester moiety by an amide function 
abolishes the hydrolytic activity of the enzyme; therefore, selec- 
tive hydrolysis of short-chain oxidation products from en- 
dogenous and exogenous ester phospholipids of LDL by PAF- 
AH could result in significant differences in terms of apoB 
modification when compared to alterations caused by unhydro- 
lyzable fragments of an amide analogue like PLA. To test this 
hypothesis, LDL samples were oxidized in the presence of equal 
amounts of the two exogenous phospholipids PLE and PLA 
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(300/2M) and the rates of the receptor-mediated endocytosis 
were monitored. When LDL was subjected to Cu2+-initiated 
oxidation (24 h) in the presence of PLE, the uptake of the 
modified lipoprotein (PLE-LDL) by P388D1 macrophage-like 
cells was enhanced by an additional 17% compared to oxLDL 
which was not subjected to any additions except copper (Table 
1). Radioiodinated LDL oxidized together with PLA (PLA- 
LDL) was ingested at somewhat reduced rates: approxima- 
tively 9% less radioactivity was recovered from the cells than 
from oxLDL. Relative to PLA-LDL, PLE-LDL was taken up 
at a 1.33-fold rate. After 12 h of oxidation this difference was 
less pronounced (1.13-fold increased rate). The uptake of LDL 
modified with preoxidized PLE differed from native LDL-up- 
take by an additional 10%. As for treatment of LDL with the 
preoxidized amide analog PLA, the uptake was even reduced 
by 13% (relative to native LDL). Treatment of oxidized 
phospholipids with immobilized bee venom phospholipase 
prior to its addition to native LDL, however, markedly en- 
hanced the difference found for the ingestion of both particles 
(Table 1). Thirty-five percent more PLAz-PLE-LDL than 
PLA2-PLA-LDL was ingested. The results obtained from 
quantification by endocytosis did not correspond to the degree 
of modification estimated by TNBS titration of reactive amino 
groups (Table 1). No significant difference in the number of free 
lysine groups of oxLDL, PLE- LDL and PLA-LDL could be 
obtained, while a total reduction of about 40% compared to 
native LDL was found. 
To ensure that differences in uptake were not partly due to 
interactions of oxidizing LDLs with exogenous phospholipid 
vesicles, experiments were partly repeated using LDLs enriched 
with one of the two compounds. Pretreatment of radioiodi- 
nated LDL with PLA or PLE in the presence of a phospholipid 
transfer protein-containing fraction yielded lipoproteins pre- 
loaded with unsaturated phospholipids [125I]E-LDL (using 
PLE) and [~25I]A-LDL (using PLA). To estimate the PLA or 
PLE content of these LDLs, phospholipids carrying [3H]ara- 
chidonic acid were synthesized and used as markers. Typically, 
10.5% of the radioactivity of both compounds was incorpo- 
rated, corresponding to an enrichment of about 27 additional 
phospholipid molecules and an additional 30% of arachidonic 
acid/particle [29]. Radioiodinated particles, [125I]E-LDL and 
[125I]A-LDL, preloaded with non-labeled phospholipids were 
then oxidized as described above. Relative differences inuptake 
of [125I]A-LDL and [I25I]E-LDL were similar to those of the 
previous experiment; he latter LDL was ingested at an in- 
creased rate of 1.43-fold compared to [~25I]A-LDL (Table 1). 
The absolute values of the pre-loaded oxidized lipoproteins 
ingested, TNBS-sensitive modification and lipoprotein bound 
tritium were somewhat smaller than found in the first set of 
experiments. During oxidation, the LDL-associated acetylhy- 
drolase activity decreased progressively (Fig. 1). 
After 24 h, 14.0% of the starting activity was left in [~25I]E- 
LDL and 18.5% in the corresponding amide-loaded [125I]A- 
LDL. Similarly the activity of PLE- and PLA-LDL decreased. 
The results described so far apparently imply that PAF- 
acetylhydrolase or any other phospholipase A2 activity in oxi- 
dizing LDL enhances lipid accumulation i  macrophages a a 
consequence of an increased egree of protein modification. 
However, due to experimental conditions, all lipid peroxidation 
products were trapped with LDL in a closed vial. In an attempt 
to mimic physiological conditions more closely, copper-in- 
duced oxidation of phospholipid-enriched [~25I]E-LDL and 
[~25I]A-LDL was carried out in dialysis bags. Albumin (15/2M) 
was placed outside the membrane thus generating a concentra- 
tion gradient for compounds released from oxidizing lipopro- 
teins to an environment capable of functioning as an acceptor 
for aldehydes and fatty acids. Under these conditions, modifi- 
cation and uptake of the LDLs were found to be reduced when 
the data were compared to values obtained from the albumin- 
free experiments. As shown in Table 1, samples oxidized in 
dialysis bags in the presence of albumin were characterized by 
a corresponding reduction in the degree of modification of 
apoB lysines and by changes of REM in agarose lectrophore- 
sis. 
Most importantly, both the order of the REM values and the 
preference in cellular uptake of the respective phospholipid- 
Table 1 
Effect of phospholipid addition and phospholipid enrichment ofLDL on oxidative protein modification and uptake by P388D~ cells 
LDL sample % uptake a Electrophoretic Reactive amino groups [3H]-LDL-bound 
mobility (tool NHJmol apoB) b radioactivity (%)c 
nLDL 3.73 + 1.47 0.31 325 + 18 1.9 + 1.3 
oxLDL (24 h) 6.73 + 1.06 0.73 181 + 17 8.5 _+ 5.2 
PLE-LDL (12 h) 5.90 + 1.07 0.59 200 + 13 n.d. 
PLE-LDL (24 h) 7.84 + 0.130 0.70 191 _+ 18 9.7 + 6.1 
[125]E-LDL 8.46 + 0.72 ° 0.76 184 _+ 24 10.5 _+ 5.9 
oxPLE + nLDL 4.11 + 0.13 0.45 256 + 12 n.d. 
PLAz-PLE-LDL (24 h) 9.11 + 1.26 0.82 174 + 34 n.d. 
PLE-LDL + BSA (24 h) 5.45 _+ 0.65 0.57 247 _+ 17 n.d. 
PLA-LDL (12 h) 5.22 _+ 0.28 0.55 238 _+ 19 n.d. 
PLA-LDL (24 h) 6.18 _+ 0.50 d 0.67 205 + 22 9.4 _+ 6.0 
[t25]A-LDL 5.92 + 0.32 e 0.62 211 + 18 10.5 +_ 4.8 
oxPLA + nLDL 3.30 + 0.13 0.48 250 + 28 n.d. 
PLA2-PLA-LDL (24 h) 6.75 + 0.87 0.64 222 + 29 n.d. 
PLA-LDL + BSA (24 h) 7.68 _+ 0.35 0.70 212 +_ 18 n.d. 
n.d. not determined. 
Uptake of [~2S]-labelled ipoproteins relative to native LDL (100%). Mean + S.D. 
bEstimated asTNBS reactivity. Mean + S.D. 
c Mean + S.D. 
dSignificant difference as evaluated by single tailed t-test (P<0.01, n = 6). 
e Significant difference as evaluated by single tailed t-test (P<0.01, n = 6). 
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enriched particles ([125I]E-LDL and [125I]A-LDL) were reversed. 
Relative to [125I]A-LDL, 43% more radioactivity was measured 
in cells treated with [125I]E-LDL (Table 1). While REM and 
uptake of radioactivity in macrophages showed good correla- 
tion (r 2 = 0.831, including all data displayed in Table 1), corre- 
lation of uptake and lysine modification was poor (r 2 = 0.655). 
4. Discussion 
Our results indicate that the addition of the two exogenous 
phospholipids PLA and PLE to oxidizing LDL causes distinct 
effects in terms of modification and uptake by P388D~ cells. 
While PLE enhances electrophoretic mobility, protein modifi- 
cation and ingestion by P388Dl macrophage-like c lls in the 
first set of experiments, the opposite is observed for the amide 
analog PLA. 
A similar result is obtained when native LDL is modified 
with peroxidized phospholipids. The degree of modification is, 
however, found to be somewhat reduced, which suggests that 
in situ scavenging of oxidation products by apolipoprotein B 
may be more efficient. The short interaction time of oxidized 
phospholipids with LDL (2 h) may contribute to this effect. 
Addition of exogenous PLA 2 to oxidized phospholipids prior 
to incubation with LDL, however, markedly increases the 
differences between the two LDLs in terms of protein modifica- 
tion and macrophage uptake. Therefore, variations in the hy- 
drolytic stability of the sn-2-substituents are apparently accom- 
panied by changes in the peroxidative modification of apoB 100 
and thus in receptor recognition. Since both exogenously added 
phospholipids differ only marginally in their physicochemical 
properties, the finding of distinct rates of cellular uptake is most 
likely a consequence of a discriminating action of a LDL- 
associated phospholipase A2, most likely identical with PAF- 
acetylhydrolase. 
During LDL oxidation a concomittant loss of enzyme activ- 
ity has been observed. Our data are in good agreement with 
previous reports dealing with the inactivation of this enzyme 
in the course of oxidation [31]. The authors uggested the gen- 
eration of non-competitively inhibiting oxidation products as 
4-hydroxynonenal r ther than substrate dilution by oxidized 
phospholipids. In line with that, the inhibitory effect was not 
found to be altered dramatically by non-hydrolyzable short- 
chain substrate analogs potentially generated by oxidative frag- 
mentation of PLA. On the contrary, a somewhat larger hydro- 
lase activity remained when [~25I]A-LDL was oxidized. Despite 
a progressive loss of enzyme activity, data from both studies are 
not in conflict with the hypothesis that acetylhydrolase affects 
the composition of peroxidation products ince significant en- 
zymatic activity (appr. 15 25%) is left after 24 h of oxidation. 
Insertion of the phospholipids in the LDL layer with transfer 
proteins lightly diminished the differences between the LDL 
samples, probably due to an overall increased ratio of en- 
dogenously available to exogenously added unsaturated com- 
ponents, diminishing the differences present in both prepara- 
tions. A detailed analysis of parameters, like concentration and 
packing of phospholipids in LDL, however, was not within the 
scope of this study, although other results suggest that experi- 
ments involving other phospholipids may provide further in- 
sight into factors determining LDL oxidation and modification 
[32]. While it is reasonable to assign differences in uptake to the 
LDL-associated acetylhydrolase, one critical point in this con- 
text is to precisely quantify the PAF-AH-mediated effect. Since 
endogenous sn-2-ester phospholipids till represent the main 
part in samples treated with PLA, as determined by means of 
tritiated compounds, differences of the LDLs in terms of mod- 
ification and uptake may represent only a part of a PAF-AH- 
mediated effect possible. 
Our findings can be interpreted as depicted in Scheme 1. 
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Fig. |. Change in PAE-AH activity (%) during 24-h co-oxidation of [~25[]LDL with PLE and PLA or by modification of 24-h preoxidized PLE or 
PLA with native [I251]LDL for 1 h (means of three samples). 
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Oxidative degradation of PLA gives phospholipids with frag- 
mented sn-2 residues. The action of PAF-AH on peroxidatively 
fragmented short-chain ester phospholipids from PLE yields 
lysophospholipids and, among other products, bifunctional al- 
dehydic carboxylic acids. A very simplistic stoichiometric ra- 
tionalization of potentially PAF-AH-dependent processes sug- 
gests that one molecule of phospholipid PLA initially gives two 
compounds, one aldehydic phospholipid and one aldehyde. 
Provided that there is complete hydrolysis, oxidation of PLE 
in the presence of an active hydrolase affords at least one 
molecule of lysophospholipid, one aldehyde and one acidic 
aldehyde. PAF-acetylhydrolase-catalyzed hydrolysis in concert 
with lipid peroxidation thus may provide more reactive hydro- 
philic products and consistently, a phospholipid carrying a 
5-oxovalerate at the sn-2 position has been identified in oxi- 
dized phosphatidylcholine [14]. On the other hand, consecutive 
products of PLA-LDL probably comprise compounds which 
are more lipophilic and less reactive due to steric hindrance 
created by the carbon chain length. Hydrolytic activity conse- 
quently may cause enhanced protein modification, scavenger 
receptor binding and subsequent cellular uptake of PLE-LDL. 
Reactions of lipid fragments with proteins, besides of chemical 
reactivity, therefore may be affected by water solubility and 
partitioning between an aqueous and a lipophilic environment. 
Whether PAF-AH-dependent generation of aldehydic acids 
plays a significant role in modification of apoprotein B cannot 
be assessed at the present time. A formation of such species has 
been previously postulated by Esterbauer [33,34], however, ex- 
perimental evidence of such species has been hampered so far 
by the lack of an appropriate method for quantitative determi- 
nation. 
It must be taken into account hat the experimental design 
in the first set of experiments precludes free diffusion of reactive 
hydrophilic products, an issue which most certainly results in 
an overall enhanced egree of apoB modification due to an 
increased reaction rate of LDL-unbound fragments. Despite 
the fact that the site of LDL oxidation is unknown, it is reason- 
able to assume deviating conditions for LDL oxidation in vivo. 
Factors affecting LDL modification in vivo may include the 
presence of scavenging proteins capable of competing with 
apoB 100 for reaction with aldehydic agents; in short this means 
that the composition of the microenvironment may be critical. 
Therefore modification and uptake was investigated in a second 
set of experiments. As reported by this laboratory previously 
[35], albumin may be capable of protecting LDL from degrada- 
tion via scavenger-dependent pathways by properties distinct 
to its funtion as antioxidant. Moreover albumin, besides its 
ability to bind lysophospholipids [36-38] and its antioxidant 
properties [39], has multiple binding sites for fatty acids [40,41]. 
This may further favor the scavenging of acidic peroxidation 
products and macrophages, capable of incorporating albumin- 
bound fatty acids [42], may contribute to neutralizing reactive 
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C H2--O'-- IP--O-- (C H2)2--N(C H3)3 
/ 
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Scheme 1. Principle of the discriminating action of PAF-AH on the composition od oxidation products and subsequent apoB modification. 
R, = l-O-hexadecyl-2-desoxy-sn-glycero-3-phosphocholine; R2 = phosphocholine. 
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acidic compounds. In addition, the release of PAF-acetylhydro- 
lase activity markedly increases with the differentiation of mon- 
ocytes to macrophages [43]. 
In a recently published study, LDL protection by PAF-AH 
has been suggested and LDL-modification has been analyzed 
by an alternative approach [44]. Supplementation f purified 
PAF-acetylhydrolase from erythrocytes as well as inhibitor pre- 
treatment caused a reduced electrophoretic mobility of oxidized 
LDL. However, despite an apparent correlation between cellu- 
lar uptake and electrophoretic mobility, this does not necessar- 
ily imply causal linkage and changes in conformation and/or 
apolipoprotein oxidation may be critical as well [45, 46]. 
Taken together, the results of the current study are in accord 
with a LDL protective role of PAF-acetylhydrolase activities 
in terms of oxidative modification and subsequent uptake by 
macrophages. Our experimental design ensured that sample 
groups to be compared were supplemented with an equal 
amount of exogenous phospholipid thus excluding any parame- 
ters except the varying susceptibility of oxidatively generated 
phospholipid erivatives to enzymatic hydrolysis with high 
probability. The most likely interpretation of the differences 
observed in the LDL preparations i that the presence of a 
hydrolytic activity in LDL favors the release of oxidation prod- 
ucts which tend to escape from reaction with LDL due to 
diffusion in an aqueous environment. Accordingly, diffusion 
and/or attachment to additional binding sites appear to be a 
prerequesite for a beneficial effect of phospholipases in this 
context. However, since hydrolytic activity is likely to affect the 
whole pattern of oxidation products, more experiments are 
needed to analyze variations in biological activity, like cellular 
toxicity and mutagenicity, in order to establish a protective 
physiological role of PAF-AH during LDL-oxidation. 
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